価格表

在庫・価格 : 2025年06月24日 19時47分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Influenza A Virus NP (Nucleoprotein), Rabbit-Poly
データシート
GTX125989 GNTジーンテックス
GeneTex International Corporation
100 μl ¥85,000
(未発注)
追加

在庫・価格 : 2025年06月24日 19時47分 現在

Anti-Influenza A Virus NP (Nucleoprotein), Rabbit-Poly

  • 商品コード:GTX125989
  • メーカー:GNT
  • 包装:100μl
  • 価格: ¥85,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhang Z et al. Infectious Progeny of 2009 A (H1N1) Influenza Virus Replicated in and Released from Human Neutrophils. Sci Rep 2015 Dec;5:17809
Zhang Z et al
2015/01/01
PubMed
2 Li YT et al. Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan. PLoS ONE 2015;10(8):e0133910
Li YT et al
2015/01/01
PubMed
3 Sun H et al. The infection of turkeys and chickens by reassortants derived from pandemic H1N1 2009 and avian H9N2 influenza viruses. Sci Rep 2015 Jun;5:10130
Sun H et al
2015/01/01
PubMed
4 Makau JN et al. Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches. PLoS ONE 2017;12(3):e0173582
Makau JN et al
2017/01/01
PubMed
5 Zhang S et al. Sus scrofa miR-204 and miR-4331 Negatively Regulate Swine H1N1/2009 Influenza A Virus Replication by Targeting Viral HA and NS, Respectively. Int J Mol Sci 2017 Apr;18(4)
Zhang S et al
2017/01/01
PubMed
6 Czak坦 R et al. <i>In Vivo</i> Imaging of Influenza Virus Infection in Immunized Mice. MBio 2017 05;8(3)
Czak坦 R et al
2017/01/01
Application: IHC (Formalin-fixed paraffin-embedded sections) PubMed
7 Tawaratsumida K et al. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J. Virol. 2014 Aug;88(16):9038-48
Tawaratsumida K et al
2014/01/01
Application: Western blot PubMed
8 Hu Y et al. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res. 2017 Sep;145:103-113
Hu Y et al
2017/01/01
Application: Western blot PubMed
9 Hu Y et al. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci 2017 Sep;18(9)
Hu Y et al
2017/01/01
Application: Western Blot (WB) PubMed
10 Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
Watanabe K et al
2017/01/01
Application: Western Blot (WB) PubMed
11 Sutton TC et al. <i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice. J. Virol. 2017 12;91(24)
Sutton TC et al
2017/01/01
Application: IHC (Formalin-fixed paraffin-embedded sections) PubMed
12 Liu H et al. Mutations in the Influenza A Virus M1 Protein Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail. J. Virol. 2018 01;92(1)
Liu H et al
2018/01/01
Application: Western Blot (WB) PubMed
13 Rowell J et al. Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice. Vaccine 2018 02;36(7):1008-1015
Rowell J et al
2018/01/01
Application: Western Blot (WB) PubMed
14 Chen L et al. N-myc downstream-regulated gene 1 facilitates influenza A virus replication by suppressing canonical NF-&#x3BA;B signaling. Virus Res. 2018 07;252:22-28
Chen L et al
2018/01/01
Application: Western Blot (WB) PubMed
15 Chida J et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018 05;14(5):e1007049
Chida J et al
2018/01/01
Application: Western Blot (WB) PubMed
16 Wessels U et al. A Dual Motif in the Hemagglutinin of H5N1 Goose/Guangdong-Like Highly Pathogenic Avian Influenza Virus Strains Is Conserved from Their Early Evolution and Increases both Membrane Fusion pH and Virulence. J. Virol. 2018 09;92(17)
Wessels U et al
2018/01/01
Application: Western Blot (WB) PubMed
17 Wang J et al. Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus. Viruses 2018 06;10(6)
Wang J et al
2018/01/01
Application: Western Blot (WB) PubMed
18 Giese S et al. Role of influenza A virus NP acetylation on viral growth and replication. Nat Commun 2017 11;8(1):1259
Giese S et al
2017/01/01
PubMed
19 Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
Lin HT et al
2018/01/01
Application: Western Blot PubMed
20 Yang C et al. The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus. J. Virol. 2018 Sep;
Yang C et al
2018/01/01
Application: Western Blot,Immunocytochemistry/ Immunofluorescence PubMed
21 Mizuta S et al. Synthesis of Trifluoromethyl-&#x3B1;,&#x3B2;-unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors. ChemMedChem 2018 Nov;13(22):2390-2399
Mizuta S et al
2018/01/01
Application: Western Blot PubMed
22 Ciminski K et al. Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11. Emerg Microbes Infect 2019;8(1):556-563
Ciminski K et al
2019/01/01
Application: Western Blot PubMed
23 Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
Zhang J et al
2019/01/01
Application: Western Blot PubMed
24 Zhao L et al. The Downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2. Mol Ther Nucleic Acids 2019 Mar;14:509-519
Zhao L et al
2019/01/01
Application: Western Blot PubMed
25 Mohl G et al. Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5. Antiviral Res. 2019 Apr;164:81-90
Mohl G et al
2019/01/01
PubMed
26 Wu XX et al. Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection. Emerg Microbes Infect 2020 Dec;9(1):962-975
Wu XX et al
2020/01/01
PubMed
27 Makau JN et al. A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants. Viruses 2020 03;12(3)
Makau JN et al
2020/01/01
PubMed
28 Zhang T et al. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis. Cell 2020 Mar;180(6):1115-1129.e13
Zhang T et al
2020/01/01
PubMed
29 Hu A et al. Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase. Front Microbiol 2020;11:178
Hu A et al
2020/01/01
PubMed
30 Chao TL et al. Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. Front Microbiol 2019;10:2942
Chao TL et al
2019/01/01
PubMed
31 Chen WC et al. Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections. J. Med. Chem. 2020 02;63(3):1313-1327
Chen WC et al
2020/01/01
PubMed
32 Cai M et al. The R251K Substitution in Viral Protein PB2 Increases Viral Replication and Pathogenicity of Eurasian Avian-like H1N1 Swine Influenza Viruses. Viruses 2020 01;12(1)
Cai M et al
2020/01/01
PubMed
33 Hao X et al. The PB2 and M genes are critical for the superiority of genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza viruses in mice. Transbound Emerg Dis 2020 Mar;67(2):758-768
Hao X et al
2020/01/01
PubMed
34 Park YH et al. Host-Specific Restriction of Avian Influenza Virus Caused by Differential Dynamics of ANP32 Family Members. J. Infect. Dis. 2020 01;221(1):71-80
Park YH et al
2020/01/01
PubMed
35 Ciminski K et al. Bat influenza viruses transmit among bats but are poorly adapted to non-bat species. Nat Microbiol 2019 12;4(12):2298-2309
Ciminski K et al
2019/01/01
PubMed
36 Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
Choi JG et al
2019/01/01
PubMed
37 Hao X et al. The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens. Virology 2019 09;535:218-226
Hao X et al
2019/01/01
PubMed
38 Zheng W et al. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export. Cell Rep 2019 05;27(6):1875-1885.e5
Zheng W et al
2019/01/01
PubMed
39 Luo Z et al. Epigoitrin, an Alkaloid From <i>Isatis indigotica</i>, Reduces H1N1 Infection in Stress-Induced Susceptible Model <i>in vivo</i> and <i>in vitro</i>. Front Pharmacol 2019;10:78
Luo Z et al
2019/01/01
PubMed
40 Te Velthuis AJW et al. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat Microbiol 2018 11;3(11):1234-1242
Te Velthuis AJW et al
2018/01/01
PubMed
41 Wohlgemuth N et al. Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication. J. Virol. 2018 11;92(22)
Wohlgemuth N et al
2018/01/01
PubMed
42 Lambertz RLO et al. Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice. J. Gen. Virol. 2018 09;99(9):1187-1198
Lambertz RLO et al
2018/01/01
PubMed
43 Wang B et al. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins. Front Immunol 2018;9:1193
Wang B et al
2018/01/01
PubMed
44 Guo K et al. Proteomic analysis of chicken embryo fibroblast cells infected with recombinant H5N1 avian influenza viruses with and without NS1 eIF4GI binding domain. Oncotarget 2018 Feb;9(9):8350-8367
Guo K et al
2018/01/01
PubMed
45 Chen L et al. Histone Deacetylase 1 Plays an Acetylation-Independent Role in Influenza A Virus Replication. Front Immunol 2017;8:1757
Chen L et al
2017/01/01
PubMed
46 Oh SJ et al. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response. Cells 2021 03;10(3)
Oh SJ et al
2021/01/01
PubMed
47 Liu Y et al. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective. Vet Microbiol 2021 Mar;254:108997
Liu Y et al
2021/01/01
PubMed
48 Gong W et al. Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. J Virol 2021 Mar;
Gong W et al
2021/01/01
PubMed
49 Wang B et al. Differences in Highly Pathogenic H5N6 Avian Influenza Viral Pathogenicity and Inflammatory Response in Chickens and Ducks. Front Microbiol 2021;12:593202
Wang B et al
2021/01/01
PubMed
50 Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
Zhu Y et al
2020/01/01
PubMed
51 Lambertz RLO et al. H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice. Virol J 2020 04;17(1):56
Lambertz RLO et al
2020/01/01
PubMed
52 Gopal V et al. Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus. bioRxiv 2020 Nov;
Gopal V et al
2020/01/01
PubMed
53 Gao Q et al. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus. J Virol 2020 12;95(2)
Gao Q et al
2020/01/01
PubMed
54 Luo Z et al. Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-&#x3B2; responses by Mfn2-mediated ubiquitin degradation of MAVS. Signal Transduct Target Ther 2020 09;5(1):202
Luo Z et al
2020/01/01
PubMed
55 Percopo CM et al. <i>Alternaria alternata</i> Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection. Viruses 2020 08;12(9)
Percopo CM et al
2020/01/01
PubMed
56 Zhang Q et al. SNW1 interacts with IKK&#x3B3; to positively regulate antiviral innate immune responses against influenza A virus infection. Microbes Infect ;22(10):576-584
Zhang Q et al
PubMed
57 Chida J et al. Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. PLoS Pathog 2020 08;16(8):e1008823
Chida J et al
2020/01/01
PubMed
58 Zhang X et al. Avian Chaperonin Containing TCP1 Subunit 5 Supports Influenza A Virus Replication by Interacting With Viral Nucleoprotein, PB1, and PB2 Proteins. Front Microbiol 2020;11:538355
Zhang X et al
2020/01/01
PubMed
59 Bao J et al. Galectin-1 Ameliorates Influenza A H1N1pdm09 Virus-Induced Acute Lung Injury. Front Microbiol 2020;11:1293
Bao J et al
2020/01/01
PubMed
60 Aartjan te Velthuis et al., Aartjan te Velthuis, bioRxiv, 2018

PubMed
61 Guo K et al., Guo K, Oncotarget, 2017

PubMed
62 Giese S et al., Giese S, Nat. Commun., 2017

PubMed
63 Qian W et al., Qian W, Front. Immunol., 2017

PubMed
64 Gopal V et al. Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus. ACS Appl Mater Interfaces 2021 Jul;13(26):30317-30325
Gopal V et al
2021/01/01
PubMed
65 Hara H et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep 2021 05;11(1):10109
Hara H et al
2021/01/01
PubMed
66 Froggatt HM et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity. PLoS Pathog 2021 09;17(9):e1009951
Froggatt HM et al
2021/01/01
PubMed
67 Huang K et al. PGRMC1 Exerts Its Function of Anti-Influenza Virus in the Central Nervous System. Microbiol Spectr 2021 10;9(2):e0073421
Huang K et al
2021/01/01
PubMed
68 Ulferts R et al. Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation. Cell Rep 2021 10;37(4):109899
Ulferts R et al
2021/01/01
PubMed
69 Kinoshita T et al. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep 2021 10;11(1):21259
Kinoshita T et al
2021/01/01
PubMed
70 Wang J et al. Osteopontin aggravates acute lung injury in influenza virus infection by promoting macrophages necroptosis. Cell Death Discov 2022 Mar;8(1):97
Wang J et al
2022/01/01
PubMed
71 Wu XX et al. The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus. Virol J 2021 Nov;18(1):237
Wu XX et al
2021/01/01
PubMed
72 Gerlt V et al. Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection. Int J Mol Sci 2021 Oct;22(20)
Gerlt V et al
2021/01/01
PubMed
73 Mao X et al. Essential Oil-Rich Chinese Formula Luofushan-Baicao Oil Inhibits the Infection of Influenza A Virus through the Regulation of NF-<i>&#x3BA;</i>B P65 and IRF3 Activation. Evid Based Complement Alternat Med 2021;2021:5547424
Mao X et al
2021/01/01
PubMed
74 Nakano M et al. Ultrastructure of influenza virus ribonucleoprotein complexes during viral RNA synthesis. Commun Biol 2021 Jul;4(1):858
Nakano M et al
2021/01/01
PubMed
75 Zhao Y et al. <i>CMAS</i> and <i>ST3GAL4</i> Play an Important Role in the Adsorption of Influenza Virus by Affecting the Synthesis of Sialic Acid Receptors. Int J Mol Sci 2021 Jun;22(11)
Zhao Y et al
2021/01/01
PubMed
76 Patil A et al. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function. J Virol 2021 Feb;95(6)
Patil A et al
2021/01/01
PubMed
77 Huang K et al. 139D in NS1 Contributes to the Virulence of H5N6 Influenza Virus in Mice. Front Vet Sci 2021;8:808234
Huang K et al
2021/01/01
PubMed
78 Zhao J et al. An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nat Commun 2022 Apr;13(1):2079
Zhao J et al
2022/01/01
PubMed
79 Zou J et al. Transportin-3 Facilitates Uncoating of Influenza A Virus. Int J Mol Sci 2022 Apr;23(8)
Zou J et al
2022/01/01
PubMed
80 Meng X et al. HIF-1&#x3B1; promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming. Virol Sin 2024 Feb;39(1):81-96
Meng X et al
2024/01/01
PubMed
81 WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

PubMed
82 Y Li et al., Cepharanthine inhibits influenza A virus replication by impairing viral polymerase activity and regulating influenza-induced immune response., Phytomed Plus., 2024., 4., 2., 100553

PubMed
83 Dong M et al. Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor. Virol Sin 2023 Dec;38(6):931-939
Dong M et al
2023/01/01
PubMed
84 Lamb C et al. Quantification of influenza virus mini viral RNA dynamics using Cas13. bioRxiv 2024 May;
Lamb C et al
2024/01/01
PubMed
85 Zou J et al. Prohibitin1 facilitates viral replication by impairing the RIG-I-like receptor signaling pathway. J Virol 2023 Oct;97(10):e0092623
Zou J et al
2023/01/01
PubMed
86 He M et al. Anti-influenza drug screening and inhibition of apigetrin on influenza A virus replication via TLR4 and autophagy pathways. Int Immunopharmacol 2023 Nov;124(Pt B):110943
He M et al
2023/01/01
PubMed
87 Rigby CV et al. Evolution of&#xA0;transient RNA structure-RNA polymerase interactions in&#xA0;respiratory RNA virus genomes. Virus Evol 2023;9(2):vead056
Rigby CV et al
2023/01/01
PubMed
88 Resnick JD et al. Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection. bioRxiv 2023 Aug;
Resnick JD et al
2023/01/01
PubMed
89 Zhao Z et al. Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. Viruses 2023 Jul;15(8)
Zhao Z et al
2023/01/01
PubMed
90 Kleinehr J et al. Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA. PLoS Pathog 2023 Jul;19(7):e1010986
Kleinehr J et al
2023/01/01
PubMed
91 Rigby C et al. Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes. bioRxiv 2023 Aug;
Rigby C et al
2023/01/01
PubMed
92 Luo D et al. PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a&#xA0;cap-dependent endonuclease inhibitor. Virol Sin 2023 Aug;38(4):559-567
Luo D et al
2023/01/01
PubMed
93 Zhu Y et al. N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication. PLoS Pathog 2023 Apr;19(4):e1011305
Zhu Y et al
2023/01/01
PubMed
94 Pan P et al. SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication. Signal Transduct Target Ther 2023 May;8(1):194
Pan P et al
2023/01/01
PubMed
95 Myers ML et al. Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies. Nat Commun 2023 Mar;14(1):1763
Myers ML et al
2023/01/01
PubMed
96 Chen J et al. Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. Virol Sin 2023 Feb;38(1):128-141
Chen J et al
2023/01/01
PubMed
97 Hao Q et al. Inducible general knockout of Runx3 profoundly reduces pulmonary cytotoxic CD8<sup>+</sup> T cells with minimal effect on outcomes in mice following influenza infection. Front Immunol 2022;13:1011922
Hao Q et al
2022/01/01
PubMed
98 Xiao YN et al. Tropism and Infectivity of Pandemic Influenza A H1N1/09 Virus in the Human Placenta. Viruses 2022 Dec;14(12)
Xiao YN et al
2022/01/01
PubMed
99 Jiang J et al. LncNSPL facilitates influenza A viral immune escape by restricting TRIM25-mediated K63-linked RIG-I ubiquitination. iScience 2022 Jul;25(7):104607
Jiang J et al
2022/01/01
PubMed
100 Zheng H et al. G Protein Subunit &#x3B2;1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2. J Virol 2022 Jun;96(12):e0049422
Zheng H et al
2022/01/01
PubMed
101 Diefenbacher M et al. Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression. J Virol 2022 May;96(10):e0020522
Diefenbacher M et al
2022/01/01
PubMed
102 G端nl F et al. The ubiquitination landscape of the influenza A virus polymerase. Nat Commun 2023 Feb;14(1):787
G端nl F et al
2023/01/01
PubMed
103 Panagiotidis GD et al. Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Arch Virol 2023 Jan;168(2):63
Panagiotidis GD et al
2023/01/01
PubMed
104 Chen Y et al. Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza. Influenza Other Respir Viruses 2023 Mar;17(3):e13112
Chen Y et al
2023/01/01
PubMed
105 Huang Y et al. Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process. Viruses 2022 Dec;14(12)
Huang Y et al
2022/01/01
PubMed
106 Hui X et al. In vitro and in vivo effects of 3-indoleacetonitrile-A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection. Antiviral Res 2023 Jan;209:105465
Hui X et al
2023/01/01
PubMed
107 Li Q et al. SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. Adv Sci (Weinh) 2022 Dec;9(34):e2203088
Li Q et al
2022/01/01
PubMed
108 French H et al. Transient RNA structures cause aberrant influenza virus replication and innate immune activation. Sci Adv 2022 Sep;8(36):eabp8655
French H et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Zhang Z et al. Infectious Progeny of 2009 A (H1N1) Influenza Virus Replicated in and Released from Human Neutrophils. Sci Rep 2015 Dec;5:17809
    Zhang Z et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Li YT et al. Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan. PLoS ONE 2015;10(8):e0133910
    Li YT et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sun H et al. The infection of turkeys and chickens by reassortants derived from pandemic H1N1 2009 and avian H9N2 influenza viruses. Sci Rep 2015 Jun;5:10130
    Sun H et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Makau JN et al. Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches. PLoS ONE 2017;12(3):e0173582
    Makau JN et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zhang S et al. Sus scrofa miR-204 and miR-4331 Negatively Regulate Swine H1N1/2009 Influenza A Virus Replication by Targeting Viral HA and NS, Respectively. Int J Mol Sci 2017 Apr;18(4)
    Zhang S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Czak坦 R et al. <i>In Vivo</i> Imaging of Influenza Virus Infection in Immunized Mice. MBio 2017 05;8(3)
    Czak坦 R et al
    2017/01/01
  • 備考:
    Application: IHC (Formalin-fixed paraffin-embedded sections)
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Tawaratsumida K et al. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J. Virol. 2014 Aug;88(16):9038-48
    Tawaratsumida K et al
    2014/01/01
  • 備考:
    Application: Western blot
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hu Y et al. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res. 2017 Sep;145:103-113
    Hu Y et al
    2017/01/01
  • 備考:
    Application: Western blot
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Hu Y et al. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci 2017 Sep;18(9)
    Hu Y et al
    2017/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
    Watanabe K et al
    2017/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sutton TC et al. <i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice. J. Virol. 2017 12;91(24)
    Sutton TC et al
    2017/01/01
  • 備考:
    Application: IHC (Formalin-fixed paraffin-embedded sections)
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Liu H et al. Mutations in the Influenza A Virus M1 Protein Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail. J. Virol. 2018 01;92(1)
    Liu H et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Rowell J et al. Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice. Vaccine 2018 02;36(7):1008-1015
    Rowell J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Chen L et al. N-myc downstream-regulated gene 1 facilitates influenza A virus replication by suppressing canonical NF-&#x3BA;B signaling. Virus Res. 2018 07;252:22-28
    Chen L et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Chida J et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018 05;14(5):e1007049
    Chida J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Wessels U et al. A Dual Motif in the Hemagglutinin of H5N1 Goose/Guangdong-Like Highly Pathogenic Avian Influenza Virus Strains Is Conserved from Their Early Evolution and Increases both Membrane Fusion pH and Virulence. J. Virol. 2018 09;92(17)
    Wessels U et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Wang J et al. Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus. Viruses 2018 06;10(6)
    Wang J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Giese S et al. Role of influenza A virus NP acetylation on viral growth and replication. Nat Commun 2017 11;8(1):1259
    Giese S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
    Lin HT et al
    2018/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Yang C et al. The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus. J. Virol. 2018 Sep;
    Yang C et al
    2018/01/01
  • 備考:
    Application: Western Blot,Immunocytochemistry/ Immunofluorescence
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Mizuta S et al. Synthesis of Trifluoromethyl-&#x3B1;,&#x3B2;-unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors. ChemMedChem 2018 Nov;13(22):2390-2399
    Mizuta S et al
    2018/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Ciminski K et al. Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11. Emerg Microbes Infect 2019;8(1):556-563
    Ciminski K et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
    Zhang J et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Zhao L et al. The Downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2. Mol Ther Nucleic Acids 2019 Mar;14:509-519
    Zhao L et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Mohl G et al. Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5. Antiviral Res. 2019 Apr;164:81-90
    Mohl G et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Wu XX et al. Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection. Emerg Microbes Infect 2020 Dec;9(1):962-975
    Wu XX et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Makau JN et al. A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants. Viruses 2020 03;12(3)
    Makau JN et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Zhang T et al. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis. Cell 2020 Mar;180(6):1115-1129.e13
    Zhang T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Hu A et al. Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase. Front Microbiol 2020;11:178
    Hu A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Chao TL et al. Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. Front Microbiol 2019;10:2942
    Chao TL et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Chen WC et al. Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections. J. Med. Chem. 2020 02;63(3):1313-1327
    Chen WC et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Cai M et al. The R251K Substitution in Viral Protein PB2 Increases Viral Replication and Pathogenicity of Eurasian Avian-like H1N1 Swine Influenza Viruses. Viruses 2020 01;12(1)
    Cai M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Hao X et al. The PB2 and M genes are critical for the superiority of genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza viruses in mice. Transbound Emerg Dis 2020 Mar;67(2):758-768
    Hao X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Park YH et al. Host-Specific Restriction of Avian Influenza Virus Caused by Differential Dynamics of ANP32 Family Members. J. Infect. Dis. 2020 01;221(1):71-80
    Park YH et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Ciminski K et al. Bat influenza viruses transmit among bats but are poorly adapted to non-bat species. Nat Microbiol 2019 12;4(12):2298-2309
    Ciminski K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
    Choi JG et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Hao X et al. The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens. Virology 2019 09;535:218-226
    Hao X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Zheng W et al. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export. Cell Rep 2019 05;27(6):1875-1885.e5
    Zheng W et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Luo Z et al. Epigoitrin, an Alkaloid From <i>Isatis indigotica</i>, Reduces H1N1 Infection in Stress-Induced Susceptible Model <i>in vivo</i> and <i>in vitro</i>. Front Pharmacol 2019;10:78
    Luo Z et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Te Velthuis AJW et al. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat Microbiol 2018 11;3(11):1234-1242
    Te Velthuis AJW et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Wohlgemuth N et al. Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication. J. Virol. 2018 11;92(22)
    Wohlgemuth N et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Lambertz RLO et al. Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice. J. Gen. Virol. 2018 09;99(9):1187-1198
    Lambertz RLO et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Wang B et al. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins. Front Immunol 2018;9:1193
    Wang B et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Guo K et al. Proteomic analysis of chicken embryo fibroblast cells infected with recombinant H5N1 avian influenza viruses with and without NS1 eIF4GI binding domain. Oncotarget 2018 Feb;9(9):8350-8367
    Guo K et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Chen L et al. Histone Deacetylase 1 Plays an Acetylation-Independent Role in Influenza A Virus Replication. Front Immunol 2017;8:1757
    Chen L et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Oh SJ et al. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response. Cells 2021 03;10(3)
    Oh SJ et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Liu Y et al. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective. Vet Microbiol 2021 Mar;254:108997
    Liu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Gong W et al. Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. J Virol 2021 Mar;
    Gong W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Wang B et al. Differences in Highly Pathogenic H5N6 Avian Influenza Viral Pathogenicity and Inflammatory Response in Chickens and Ducks. Front Microbiol 2021;12:593202
    Wang B et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
    Zhu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Lambertz RLO et al. H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice. Virol J 2020 04;17(1):56
    Lambertz RLO et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Gopal V et al. Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus. bioRxiv 2020 Nov;
    Gopal V et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Gao Q et al. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus. J Virol 2020 12;95(2)
    Gao Q et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Luo Z et al. Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-&#x3B2; responses by Mfn2-mediated ubiquitin degradation of MAVS. Signal Transduct Target Ther 2020 09;5(1):202
    Luo Z et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Percopo CM et al. <i>Alternaria alternata</i> Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection. Viruses 2020 08;12(9)
    Percopo CM et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Zhang Q et al. SNW1 interacts with IKK&#x3B3; to positively regulate antiviral innate immune responses against influenza A virus infection. Microbes Infect ;22(10):576-584
    Zhang Q et al
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Chida J et al. Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. PLoS Pathog 2020 08;16(8):e1008823
    Chida J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Zhang X et al. Avian Chaperonin Containing TCP1 Subunit 5 Supports Influenza A Virus Replication by Interacting With Viral Nucleoprotein, PB1, and PB2 Proteins. Front Microbiol 2020;11:538355
    Zhang X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Bao J et al. Galectin-1 Ameliorates Influenza A H1N1pdm09 Virus-Induced Acute Lung Injury. Front Microbiol 2020;11:1293
    Bao J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Aartjan te Velthuis et al., Aartjan te Velthuis, bioRxiv, 2018

  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Guo K et al., Guo K, Oncotarget, 2017

  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Giese S et al., Giese S, Nat. Commun., 2017

  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Qian W et al., Qian W, Front. Immunol., 2017

  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Gopal V et al. Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus. ACS Appl Mater Interfaces 2021 Jul;13(26):30317-30325
    Gopal V et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Hara H et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep 2021 05;11(1):10109
    Hara H et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Froggatt HM et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity. PLoS Pathog 2021 09;17(9):e1009951
    Froggatt HM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Huang K et al. PGRMC1 Exerts Its Function of Anti-Influenza Virus in the Central Nervous System. Microbiol Spectr 2021 10;9(2):e0073421
    Huang K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Ulferts R et al. Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation. Cell Rep 2021 10;37(4):109899
    Ulferts R et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Kinoshita T et al. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep 2021 10;11(1):21259
    Kinoshita T et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Wang J et al. Osteopontin aggravates acute lung injury in influenza virus infection by promoting macrophages necroptosis. Cell Death Discov 2022 Mar;8(1):97
    Wang J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Wu XX et al. The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus. Virol J 2021 Nov;18(1):237
    Wu XX et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Gerlt V et al. Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection. Int J Mol Sci 2021 Oct;22(20)
    Gerlt V et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Mao X et al. Essential Oil-Rich Chinese Formula Luofushan-Baicao Oil Inhibits the Infection of Influenza A Virus through the Regulation of NF-<i>&#x3BA;</i>B P65 and IRF3 Activation. Evid Based Complement Alternat Med 2021;2021:5547424
    Mao X et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Nakano M et al. Ultrastructure of influenza virus ribonucleoprotein complexes during viral RNA synthesis. Commun Biol 2021 Jul;4(1):858
    Nakano M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Zhao Y et al. <i>CMAS</i> and <i>ST3GAL4</i> Play an Important Role in the Adsorption of Influenza Virus by Affecting the Synthesis of Sialic Acid Receptors. Int J Mol Sci 2021 Jun;22(11)
    Zhao Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Patil A et al. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function. J Virol 2021 Feb;95(6)
    Patil A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Huang K et al. 139D in NS1 Contributes to the Virulence of H5N6 Influenza Virus in Mice. Front Vet Sci 2021;8:808234
    Huang K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Zhao J et al. An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nat Commun 2022 Apr;13(1):2079
    Zhao J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Zou J et al. Transportin-3 Facilitates Uncoating of Influenza A Virus. Int J Mol Sci 2022 Apr;23(8)
    Zou J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Meng X et al. HIF-1&#x3B1; promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming. Virol Sin 2024 Feb;39(1):81-96
    Meng X et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Y Li et al., Cepharanthine inhibits influenza A virus replication by impairing viral polymerase activity and regulating influenza-induced immune response., Phytomed Plus., 2024., 4., 2., 100553

  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Dong M et al. Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor. Virol Sin 2023 Dec;38(6):931-939
    Dong M et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Lamb C et al. Quantification of influenza virus mini viral RNA dynamics using Cas13. bioRxiv 2024 May;
    Lamb C et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Zou J et al. Prohibitin1 facilitates viral replication by impairing the RIG-I-like receptor signaling pathway. J Virol 2023 Oct;97(10):e0092623
    Zou J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    He M et al. Anti-influenza drug screening and inhibition of apigetrin on influenza A virus replication via TLR4 and autophagy pathways. Int Immunopharmacol 2023 Nov;124(Pt B):110943
    He M et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Rigby CV et al. Evolution of&#xA0;transient RNA structure-RNA polymerase interactions in&#xA0;respiratory RNA virus genomes. Virus Evol 2023;9(2):vead056
    Rigby CV et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Resnick JD et al. Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection. bioRxiv 2023 Aug;
    Resnick JD et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Zhao Z et al. Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. Viruses 2023 Jul;15(8)
    Zhao Z et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Kleinehr J et al. Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA. PLoS Pathog 2023 Jul;19(7):e1010986
    Kleinehr J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Rigby C et al. Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes. bioRxiv 2023 Aug;
    Rigby C et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Luo D et al. PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a&#xA0;cap-dependent endonuclease inhibitor. Virol Sin 2023 Aug;38(4):559-567
    Luo D et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Zhu Y et al. N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication. PLoS Pathog 2023 Apr;19(4):e1011305
    Zhu Y et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Pan P et al. SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication. Signal Transduct Target Ther 2023 May;8(1):194
    Pan P et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Myers ML et al. Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies. Nat Commun 2023 Mar;14(1):1763
    Myers ML et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Chen J et al. Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. Virol Sin 2023 Feb;38(1):128-141
    Chen J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Hao Q et al. Inducible general knockout of Runx3 profoundly reduces pulmonary cytotoxic CD8<sup>+</sup> T cells with minimal effect on outcomes in mice following influenza infection. Front Immunol 2022;13:1011922
    Hao Q et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Xiao YN et al. Tropism and Infectivity of Pandemic Influenza A H1N1/09 Virus in the Human Placenta. Viruses 2022 Dec;14(12)
    Xiao YN et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Jiang J et al. LncNSPL facilitates influenza A viral immune escape by restricting TRIM25-mediated K63-linked RIG-I ubiquitination. iScience 2022 Jul;25(7):104607
    Jiang J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Zheng H et al. G Protein Subunit &#x3B2;1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2. J Virol 2022 Jun;96(12):e0049422
    Zheng H et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Diefenbacher M et al. Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression. J Virol 2022 May;96(10):e0020522
    Diefenbacher M et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    G端nl F et al. The ubiquitination landscape of the influenza A virus polymerase. Nat Commun 2023 Feb;14(1):787
    G端nl F et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Panagiotidis GD et al. Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Arch Virol 2023 Jan;168(2):63
    Panagiotidis GD et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Chen Y et al. Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza. Influenza Other Respir Viruses 2023 Mar;17(3):e13112
    Chen Y et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Huang Y et al. Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process. Viruses 2022 Dec;14(12)
    Huang Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Hui X et al. In vitro and in vivo effects of 3-indoleacetonitrile-A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection. Antiviral Res 2023 Jan;209:105465
    Hui X et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Li Q et al. SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. Adv Sci (Weinh) 2022 Dec;9(34):e2203088
    Li Q et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    French H et al. Transient RNA structures cause aberrant influenza virus replication and innate immune activation. Sci Adv 2022 Sep;8(36):eabp8655
    French H et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed